2021
DOI: 10.1007/s10103-020-03240-7
|View full text |Cite
|
Sign up to set email alerts
|

595-nm pulsed dye laser combined with fractional CO2 laser reduces hypertrophic scar through down-regulating TGFβ1 and PCNA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
17
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(18 citation statements)
references
References 37 publications
1
17
0
Order By: Relevance
“…A further subgroup analysis was also performed which revealed that patients at the early stage could experience more significant improvement after the treatment of combined therapy. Ablative fractional CO 2 laser technology has been employed for many years; however, it is only in recent years that this technique has been applied to the treatment of hypertrophic scars (3,4,(13)(14)(15)(16)(17)(18)(19). Several case reports firstly reported the effectiveness of ablative fractional CO 2 laser treatment for hypertrophic scars (20,21), then Makboul et al enrolled 40 patients with hypertrophic scars and confirmed ablative fractional CO 2 laser treatment as a feasible management for hypertrophic scarring (22).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A further subgroup analysis was also performed which revealed that patients at the early stage could experience more significant improvement after the treatment of combined therapy. Ablative fractional CO 2 laser technology has been employed for many years; however, it is only in recent years that this technique has been applied to the treatment of hypertrophic scars (3,4,(13)(14)(15)(16)(17)(18)(19). Several case reports firstly reported the effectiveness of ablative fractional CO 2 laser treatment for hypertrophic scars (20,21), then Makboul et al enrolled 40 patients with hypertrophic scars and confirmed ablative fractional CO 2 laser treatment as a feasible management for hypertrophic scarring (22).…”
Section: Discussionmentioning
confidence: 99%
“…Zhang et al found in their rabbit model that artesunate combined with ablative fractional CO 2 laser effectively reduces hypertrophic scarring (14). Ablative fractional CO 2 laser combined with a variety of laser therapy, such as 595-nm pulsed dye laser, can also better increase the effectiveness of the treatment of hypertrophic scars (15).…”
Section: Discussionmentioning
confidence: 99%
“… 74 Moreover, in a rabbit model, the use of a fractional CO 2 laser with a 595-nm PDL can enhance the shape and histology of hypertrophic scars by reducing TGFβ1 and proliferating cell nuclear antigen (PCNA) protein expression. 75 In addition, another study found that the mRNA expression of MMP1, 2, and 3 as well as chemokines (Chemokine (C-X-C motif) ligand 1, 2, 5, and 6) and interleukins (IL-6, IL-8, and IL-24) was considerably higher in tissue samples obtained three days following fractional Er:YAG laser treatment. 76 In terms of the treatment of IPL, it suppressed levels of IL-6, tumor necrosis factor-alpha (TNF-α), MMPs, and proteolytic enzymes while raising levels of IL-10 and TGF-β in skin cells.…”
Section: Molecular Changes Induced By Photoelectric Therapy For Scarsmentioning
confidence: 99%
“…The therapeutic challenge often appears because of the age of the patient, special location and large size of the lesion, and the inherent traumatic nature of some methods. A pulsed dye laser (PDL) is based on the selective photothermolysis principle, producing pulses at wavelengths of 585 nm and 595 nm, which are now widely used in the treatment of vascular anomalies 13,14 . The therapeutic effectiveness and safety of PDL in the context of PG have been evaluated in several studies 2,15–19 .…”
Section: Introductionmentioning
confidence: 99%
“…A pulsed dye laser (PDL) is based on the selective photothermolysis principle, producing pulses at wavelengths of 585 nm and 595 nm, which are now widely used in the treatment of vascular anomalies. 13,14 The therapeutic effectiveness and safety of PDL in the context of PG have been evaluated in several studies. 2,[15][16][17][18][19] Here, we aim to evaluate the clinical effectiveness and safety profile of 595 nm PDL for our treatment of PG in a large series of cases.…”
Section: Introductionmentioning
confidence: 99%